These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 29110357)

  • 1. The administration of blood components: a British Society for Haematology Guideline.
    Robinson S; Harris A; Atkinson S; Atterbury C; Bolton-Maggs P; Elliott C; Hawkins T; Hazra E; Howell C; New H; Shackleton T; Shreeve K; Taylor C
    Transfus Med; 2018 Feb; 28(1):3-21. PubMed ID: 29110357
    [No Abstract]   [Full Text] [Related]  

  • 2. Guidelines on the use of irradiated blood components prepared by the British Committee for Standards in Haematology blood transfusion task force.
    Treleaven J; Gennery A; Marsh J; Norfolk D; Page L; Parker A; Saran F; Thurston J; Webb D
    Br J Haematol; 2011 Jan; 152(1):35-51. PubMed ID: 21083660
    [No Abstract]   [Full Text] [Related]  

  • 3. AAGBI guidelines: the use of blood components and their alternatives 2016.
    Klein AA; Arnold P; Bingham RM; Brohi K; Clark R; Collis R; Gill R; McSporran W; Moor P; Rao Baikady R; Richards T; Shinde S; Stanworth S; Walsh TS
    Anaesthesia; 2016 Jul; 71(7):829-42. PubMed ID: 27062274
    [TBL] [Abstract][Full Text] [Related]  

  • 4. AABB contributions to plasma safety.
    Triulzi DJ
    Transfusion; 2012 May; 52 Suppl 1():5S-8S. PubMed ID: 22578373
    [No Abstract]   [Full Text] [Related]  

  • 5. British Blood Transfusion Society. Blood Component Special Interest Group Symposium. Towards 'purer and safer' blood components and blood products. London, United Kingdom, 5 May 1994. Abstracts.
    Clin Lab Haematol; 1994 Dec; 16(4):379-406. PubMed ID: 7736717
    [No Abstract]   [Full Text] [Related]  

  • 6. Prioritizing the options for enhancing blood component safety.
    Barbara J; Seghatchian J
    Transfus Apher Sci; 2001 Dec; 25(3):225. PubMed ID: 11846152
    [No Abstract]   [Full Text] [Related]  

  • 7. Transfusion safety in 2012: main messages from the SHOT Annual Report for 2012.
    Bolton-Maggs PH
    Transfus Med; 2013 Aug; 23(4):217-8. PubMed ID: 23865394
    [No Abstract]   [Full Text] [Related]  

  • 8. NBA/NBS perspective on nvCJD.
    Wallington T
    Transfus Sci; 1998 Dec; 19(4):329-30. PubMed ID: 10351146
    [No Abstract]   [Full Text] [Related]  

  • 9. Potential clinical benefits and cost savings of universal leucocyte-depletion of blood components.
    Murphy MF
    Transfus Sci; 1998 Dec; 19(4):343-6. PubMed ID: 10351149
    [No Abstract]   [Full Text] [Related]  

  • 10. Evidence-based recommendations for the use of WBC-reduced cellular blood components.
    Ratko TA; Cummings JP; Oberman HA; Crookston KP; DeChristopher PJ; Eastlund DT; Godwin JE; Sacher RA; Yawn DH; Matuszewski KA;
    Transfusion; 2001 Oct; 41(10):1310-9. PubMed ID: 11606834
    [No Abstract]   [Full Text] [Related]  

  • 11. Clinical appropriateness of blood component transfusion: regulatory requirements and standards set by the Scientific Society in Italy.
    Grazzini G
    Blood Transfus; 2008 Oct; 6(4):186-90. PubMed ID: 19112733
    [No Abstract]   [Full Text] [Related]  

  • 12. The Dublin Consensus Statement 2011 on vital issues relating to the collection and provision of blood components and plasma-derived medicinal products.
    O'Mahony B; Turner A
    Vox Sang; 2012 Feb; 102(2):140-3. PubMed ID: 21806632
    [No Abstract]   [Full Text] [Related]  

  • 13. Guidelines on the clinical use of leucocyte-depleted blood components. British Committee for Standards in Haematology, Blood Transfusion Task Force.
    Transfus Med; 1998 Mar; 8(1):59-71. PubMed ID: 9569462
    [No Abstract]   [Full Text] [Related]  

  • 14. Practical aspects of the self-assessment of the issue and administration of blood: a review of two hospitals' experiences.
    Shulman IA; Jones FS
    Am J Clin Pathol; 1997 Apr; 107(4 Suppl 1):S17-22. PubMed ID: 9124224
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Report about the haemovigilance postgraduate course of the interdisciplinary European society for haemapheresis and haemotherapy.
    Moog R
    Transfus Apher Sci; 2007 Oct; 37(2):177-8. PubMed ID: 17977795
    [No Abstract]   [Full Text] [Related]  

  • 16. The potential usefulness of thrombelastography in quality monitoring and quality improvement of blood components.
    Seghatchian J
    Transfus Apher Sci; 2009 Dec; 41(3):227-8. PubMed ID: 19800846
    [No Abstract]   [Full Text] [Related]  

  • 17. Patterns of blood component use in cirrhosis: a nationwide study.
    Desborough MJ; Hockley B; Sekhar M; Burroughs AK; Stanworth SJ; Jairath V;
    Liver Int; 2016 Apr; 36(4):522-9. PubMed ID: 26537012
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The BEST Working Party of the International Society of Blood Transfusion: an international effort to improve the quality of blood components.
    Sirchia G
    Transfusion; 1995 Mar; 35(3):254-7. PubMed ID: 7878719
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Freedom from frozen: the first British military use of lyophilised plasma in forward resuscitation.
    Gokhale SG; Scorer T; Doughty H
    J R Army Med Corps; 2016 Feb; 162(1):63-5. PubMed ID: 25535320
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Advances in transfusion medicine: gastrointestinal bleeding.
    Oakland K; Jairath V; Murphy MF
    Transfus Med; 2018 Apr; 28(2):132-139. PubMed ID: 28737229
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.